SG/CALL/NOVO-NORDISK B/650/0.1/20.12.24 Stock

Warrant

DE000SU52305

Market Closed - Boerse Frankfurt Warrants 15:41:18 2024-07-05 EDT
4.52 EUR +0.22% Intraday chart for SG/CALL/NOVO-NORDISK B/650/0.1/20.12.24
Current month-4.84%
1 month+4.39%
Date Price Change
24-07-05 4.52 +0.22%
24-07-04 4.51 +4.16%
24-07-03 4.33 -8.07%
24-07-02 4.71 -4.66%
24-07-01 4.94 +4.00%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 03:41 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SU5230
ISINDE000SU52305
Date issued 2023-12-20
Strike 650 kr
Maturity 2024-12-20 (167 Days)
Parity 10 : 1
Emission price 1.58
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 5.19
Lowest since issue 1.58
Delta0x
Omega 0.000000
Premium0x
Gearing2.85x
Moneyness 1.498
Difference Strike -324 kr
Difference Strike %-49.85%
Spread 0.12
Spread %2.59%
Intrinsic value 4.340
Present value 0.2303

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
974 DKK
Average target price
952.2 DKK
Spread / Average Target
-2.24%
Consensus